Stockreport

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)

NEURALSTEM  (CUR) 
NASDAQ:AMEX Investor Relations: investor.neuralstem.com
PDF GERMANTOWN, Md., Oct. 3, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on [Read more]